Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05565599 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

StatusActive, Not Recruiting
PhaseNot applicable
Started2022-10-21
View on ClinicalTrials.gov ↗
This is an early feasibility study is to evaluate the safety and effectiveness of the Laminar Left Atrial Appendage Closure System to treat patients with non-valvular atrial fibrillation that cannot take, or a have a reason to seek an alternative, to anticoagulant medications.

Amendment record

Amended 15 times since 2022-10-03; most recent filed 2026-08-27. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2026-08-27
Amendment Study Status v15
2026-07-02
Amendment Study Status v14
2026-06-04
Amendment Study Identification, Study Status v13
2026-05-05
Amendment Study Identification, Study Status, Study Design, Eligibility, Contacts/Locations, IPDSharing v12
2025-09-11
Amendment Study Status v11
2025-08-19
Amendment Study Identification, Study Status, Sponsor/Collaborators v10
2025-07-16
Amendment Study Status, Contacts/Locations v9
2025-07-14
Amendment Study Status, Contacts/Locations v8
2023-08-21
Amendment Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v7
2023-07-28
Amendment Study Status, Contacts/Locations v6
2023-07-19
Amendment Study Status, Contacts/Locations v5
2023-06-30
Amendment Study Status, Contacts/Locations v4
2023-04-03
Amendment Active, Not Recruiting→Recruiting Study Status, Study Design, Outcome Measures, Contacts/Locations v3
2023-01-18
Amendment Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v2
2022-10-26
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
2022-10-03
Original filing
Trial Details
NCT Number NCT05565599
Lead Sponsor Biosense Webster, Inc.
Conditions Non-valvular Atrial Fibrillation
Enrollment 58 participants
Start Date 2022-10-21
Primary Completion 2024-08-07 (estimated)
Study Completion 2028-09-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-28